Kleckner, Amber S. http://orcid.org/0000-0002-5088-1139
Kleckner, Ian R. http://orcid.org/0000-0002-9828-9986
Culakova, Eva http://orcid.org/0000-0002-9852-6515
Shayne, Michelle
Belcher, Elizabeth K. http://orcid.org/0000-0003-2071-7351
Gudina, Abdi T.
Williams, AnnaLynn M. http://orcid.org/0000-0002-7042-5851
Onitilo, Adedayo A. http://orcid.org/0000-0001-9185-0606
Hopkins, Judith O. http://orcid.org/0000-0002-9829-1242
Gross, Howard
Mustian, Karen M. http://orcid.org/0000-0001-6525-7518
Peppone, Luke J. http://orcid.org/0000-0002-0346-5191
Janelsins, Michelle C. http://orcid.org/0000-0003-2258-7247
Funding for this research was provided by:
National Cancer Institute (UG1CA189961)
National Cancer Institute (T32CA102618, R01CA231014, K07CA221931)
Article History
Received: 24 November 2021
Accepted: 30 May 2022
First Online: 9 June 2022
Declarations
:
: Ethical approval was obtained from Institutional Review Boards at University of Rochester Cancer Center and each of the 22 recruitment sites prior to enrollment. This trial was performed in accordance with the ethical standards of the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: All individual participants included in the study provided informed consent.
: N/A
: The authors declare no competing interests.